AI: DeepSeek (deepseek-chat)

Q: {
  "prompt": "Original Transcript:\n### **Medical Clerking – SBAR Format**  \n\n#### **SITUATION:**  \n**Patient:** 32-year-old **G3P2** (2 SVD, 0 miscarriages) **AFAB** presenting with **chronic pelvic pain (CPP)** for **6+ months**, worsening over the last **4 weeks**. Pain is **dull, intermittent**, localized to **lower quadrants (LQ > RQ)**, **radiating to lower back**, **exacerbated by menstruation and intercourse (dyspareunia)**. No acute red flags (e.g., hemodynamic instability, peritonism). Last menstrual period **(LMP) 10 days ago**, regular cycles **(28/5)**.  \n\n#### **BACKGROUND:**  \n- **PMHx:**  \n  - **Endometriosis** (diagnosed **laparoscopically 2019**, **Stage II**, treated with **COCP** until 2022)  \n  - **Recurrent PID** (last episode **2021**, treated with **doxycycline + metronidazole**)  \n  - **Chronic IBS** (managed with **dietary modifications + mebeverine PRN**)  \n- **ObHx:**  \n  - **2 uncomplicated term vaginal deliveries** (2017, 2020)  \n  - **No Hx of ectopic pregnancy, fibroids, or ovarian cysts**  \n- **Surgical Hx:**  \n  - **Laparoscopic excision of endometriotic deposits (2019)**  \n  - **Appendectomy (2015)**  \n- **Medications:**  \n  - **Ibuprofen 400mg TDS PRN** (partial relief)  \n  - **COCP (Microgynon 30) until 2022** (discontinued due to **migraine with aura**)  \n  - **Mebeverine 135mg TDS PRN**  \n- **Allergies:** **Nil known drug allergies (NKDA)**  \n- **Social:** **Non-smoker, occasional ETOH, works as office admin, in stable relationship**  \n\n#### **ASSESSMENT:**  \n- **Vitals (at 1430 hours):**  \n  - **BP 118/76 mmHg, HR 72 bpm, SpO₂ 98% RA, Temp 36.8°C**  \n  - **BMI 24.2**  \n- **Examination:**  \n  - **Abdomen:** Soft, non-distended, **tenderness LQ**, no guarding/rebound, **no palpable masses**  \n  - **PV exam:** **No vaginal discharge**, **cervix appears normal**, **no cervical excitation**, **uterine tenderness**, **adnexa non-tender**, **no palpable masses**  \n- **Investigations:**  \n  - **Recent USS (2 weeks ago):** **No adnexal masses, normal endometrial thickness (6mm), no free fluid**  \n  - **FBC (today):** **Hb 12.8 g/dL, WBC 6.2 x10⁹/L, Plt 245 x10⁹/L**  \n  - **CRP:** **<5 mg/L**  \n  - **LFTs/U&Es:** **Normal**  \n  - **High vaginal swab (awaiting results):** **Sent for MC&S, chlamydia/gonorrhoea NAAT**  \n  - **Urine β-hCG:** **Negative**  \n- **Differential Diagnosis:**  \n  1. **Endometriosis recurrence** (given Hx, cyclical pain, dyspareunia)  \n  2. **Chronic pelvic inflammatory disease (PID)** (given recurrent PID Hx)  \n  3. **Adenomyosis** (worsening dysmenorrhea, uterine tenderness)  \n  4. **Pelvic congestion syndrome** (chronic dull ache, postural exacerbation)  \n  5. **Musculoskeletal (e.g., pelvic floor dysfunction, nerve entrapment)**  \n\n#### **RECOMMENDATION:**  \n1. **Immediate Management:**  \n   - **Analgesia:** **Paracetamol 1g QDS + NSAID (naproxen 500mg BD) PRN**  \n   - **Consider trial of hormonal suppression** (e.g., **progestogen-only pill (POP) or Mirena IUS**) given **contraindication to COCP**  \n   - **Pelvic physio referral** (if musculoskeletal component suspected)  \n2. **Investigations:**  \n   - **Repeat TV USS if pain persists** (assess for **adenomyosis, deep infiltrating endometriosis**)  \n   - **Consider diagnostic laparoscopy if refractory** (gold standard for endometriosis)  \n   - **MRI pelvis if deep endometriosis suspected**  \n3. **Follow-Up:**  \n   - **Gynae clinic in 4/52** for reassessment  \n   - **If HVS positive for infection: treat with abx per sensitivities**  \n   - **If persistent pain: MDT discussion (pain team, gynae, physio)**  \n4. **Patient Counselling:**  \n   - **Advise on pain diary (timing, triggers, severity)**  \n   - **Discuss long-term options (e.g., GnRH analogues if severe endometriosis)**  \n\n**Plan documented by: Dr. [Name], FY2**  \n**Time: 1530 hours**  \n**For: Consultant Gynaecology Review**  \n\n*(This is a fictional case for educational purposes only.)*\n\nApply these changes:\nACCEPT: Replace \"Consider trial of hormonal suppression (e.g., progestogen-only pill (POP) or Mirena IUS) given contraindication to COCP\" with \"Offer progestogen-only pill (POP) or levonorgestrel-releasing intrauterine system (Mirena IUS) as first-line hormonal treatment given contraindication to COCP, with discussion of expected benefits (pain reduction) and potential side effects\" (Reason: According to the ESHRE guideline: 'Progestogens and the levonorgestrel-releasing intrauterine system are recommended for reducing endometriosis-associated pain.' This patient has contraindications to COCP (migraine with aura) and documented Stage II endometriosis, making POP or Mirena IUS appropriate first-line options. The guideline specifically states: 'The use of levonorgestrel-releasing intrauterine system is recommended for reducing endometriosis-associated pain.')\nACCEPT: Replace \"Consider diagnostic laparoscopy if refractory (gold standard for endometriosis)\" with \"Offer diagnostic laparoscopy with excision of visible lesions if pain persists after 3 months of medical therapy, as this patient has documented Stage II endometriosis with recurrent symptoms\" (Reason: The guideline states: 'Operative laparoscopy is recommended as a treatment option for endometriosis-associated pain' and 'Excision is superior to ablation in reducing symptoms.' Given this patient's history of surgically confirmed endometriosis and ongoing symptoms despite previous treatment, laparoscopy with excision would be appropriate if medical management fails. The guideline recommends: 'Women with deep endometriosis should be referred to a center of expertise.')\nACCEPT: Replace \"Missing: discussion of long-term postoperative hormone suppression if surgery is performed\" with \"Add: 'If laparoscopy is performed, discuss long-term postoperative hormone suppression (e.g., LNG-IUS or POP) for secondary prevention of recurrence, unless pregnancy is desired'\" (Reason: The guideline recommends: 'Offer long-term hormone treatment for the secondary prevention of endometrioma and endometriosis-associated symptom recurrence after surgical management' and specifically 'Consider postoperative use of a levonorgestrel-releasing intrauterine system or combined hormonal contraceptive for the secondary prevention of endometriosis-associated symptoms.' This is particularly relevant for this patient with recurrent symptoms after previous surgery.)\nACCEPT: Replace \"Discuss long-term options (e.g., GnRH analogues if severe endometriosis)\" with \"Discuss GnRH analogues with add-back therapy as second-line option if first-line hormonal treatments fail, explaining potential side effects and need for bone protection\" (Reason: The guideline states: 'It is recommended to prescribe GnRH agonists as a second-line treatment and consider add-back therapy to prevent bone loss.' For this patient with persistent pain, GnRH analogues would be appropriate after failure of first-line options, but the guideline emphasizes: 'Add-back therapy can prevent bone loss when used with GnRH agonists.')\nACCEPT: Replace \"Pelvic physio referral (if musculoskeletal component suspected)\" with \"Offer pelvic physiotherapy referral given chronic pain history and potential pelvic floor involvement, as part of multidisciplinary pain management\" (Reason: While evidence is limited, the guideline notes: 'Physiotherapy interventions...pelvic floor exercises have shown effectiveness' and recommends considering non-medical strategies. For this chronic pain patient, physio could address potential musculoskeletal components. The guideline states: 'Clinicians should discuss non-medical strategies for quality of life and psychological well-being in women with endometriosis.')\n\nReturn the updated transcript with these changes applied.",
  "system_prompt": "You are a medical AI assistant that applies user decisions to clinical transcripts based on guideline suggestions.\n\nYou will receive:\n1. An original transcript\n2. A list of suggestions with user decisions (accept, reject, or modify)\n3. For modifications, the user's custom text\n\nYour task is to apply only the ACCEPTED and MODIFIED suggestions to create an updated transcript. For each change:\n- ACCEPTED suggestions: Apply the suggested text exactly as provided\n- MODIFIED suggestions: Apply the user's modified text instead of the original suggestion\n- REJECTED suggestions: Leave the original text unchanged\n\nReturn the updated transcript as clean, properly formatted medical text. Maintain the original structure and formatting as much as possible while incorporating the accepted changes.\n\nImportant guidelines:\n- Only apply changes that the user has accepted or modified\n- Preserve the medical accuracy and professional tone\n- Maintain logical flow and readability\n- Do not add any explanatory text or comments\n- Return only the updated transcript",
  "session_id": "advice_1751396654555_lrnew9a7r",
  "original_transcript_length": 3882,
  "changes_applied": 5,
  "decisions_summary": {
    "accepted": 5,
    "modified": 0,
    "rejected": 0
  }
}

A: ### **Medical Clerking – SBAR Format**  

#### **SITUATION:**  
**Patient:** 32-year-old **G3P2** (2 SVD, 0 miscarriages) **AFAB** presenting with **chronic pelvic pain (CPP)** for **6+ months**, worsening over the last **4 weeks**. Pain is **dull, intermittent**, localized to **lower quadrants (LQ > RQ)**, **radiating to lower back**, **exacerbated by menstruation and intercourse (dyspareunia)**. No acute red flags (e.g., hemodynamic instability, peritonism). Last menstrual period **(LMP) 10 days ago**, regular cycles **(28/5)**.  

#### **BACKGROUND:**  
- **PMHx:**  
  - **Endometriosis** (diagnosed **laparoscopically 2019**, **Stage II**, treated with **COCP** until 2022)  
  - **Recurrent PID** (last episode **2021**, treated with **doxycycline + metronidazole**)  
  - **Chronic IBS** (managed with **dietary modifications + mebeverine PRN**)  
- **ObHx:**  
  - **2 uncomplicated term vaginal deliveries** (2017, 2020)  
  - **No Hx of ectopic pregnancy, fibroids, or ovarian cysts**  
- **Surgical Hx:**  
  - **Laparoscopic excision of endometriotic deposits (2019)**  
  - **Appendectomy (2015)**  
- **Medications:**  
  - **Ibuprofen 400mg TDS PRN** (partial relief)  
  - **COCP (Microgynon 30) until 2022** (discontinued due to **migraine with aura**)  
  - **Mebeverine 135mg TDS PRN**  
- **Allergies:** **Nil known drug allergies (NKDA)**  
- **Social:** **Non-smoker, occasional ETOH, works as office admin, in stable relationship**  

#### **ASSESSMENT:**  
- **Vitals (at 1430 hours):**  
  - **BP 118/76 mmHg, HR 72 bpm, SpO₂ 98% RA, Temp 36.8°C**  
  - **BMI 24.2**  
- **Examination:**  
  - **Abdomen:** Soft, non-distended, **tenderness LQ**, no guarding/rebound, **no palpable masses**  
  - **PV exam:** **No vaginal discharge**, **cervix appears normal**, **no cervical excitation**, **uterine tenderness**, **adnexa non-tender**, **no palpable masses**  
- **Investigations:**  
  - **Recent USS (2 weeks ago):** **No adnexal masses, normal endometrial thickness (6mm), no free fluid**  
  - **FBC (today):** **Hb 12.8 g/dL, WBC 6.2 x10⁹/L, Plt 245 x10⁹/L**  
  - **CRP:** **<5 mg/L**  
  - **LFTs/U&Es:** **Normal**  
  - **High vaginal swab (awaiting results):** **Sent for MC&S, chlamydia/gonorrhoea NAAT**  
  - **Urine β-hCG:** **Negative**  
- **Differential Diagnosis:**  
  1. **Endometriosis recurrence** (given Hx, cyclical pain, dyspareunia)  
  2. **Chronic pelvic inflammatory disease (PID)** (given recurrent PID Hx)  
  3. **Adenomyosis** (worsening dysmenorrhea, uterine tenderness)  
  4. **Pelvic congestion syndrome** (chronic dull ache, postural exacerbation)  
  5. **Musculoskeletal (e.g., pelvic floor dysfunction, nerve entrapment)**  

#### **RECOMMENDATION:**  
1. **Immediate Management:**  
   - **Analgesia:** **Paracetamol 1g QDS + NSAID (naproxen 500mg BD) PRN**  
   - **Offer progestogen-only pill (POP) or levonorgestrel-releasing intrauterine system (Mirena IUS) as first-line hormonal treatment given contraindication to COCP, with discussion of expected benefits (pain reduction) and potential side effects**  
   - **Offer pelvic physiotherapy referral given chronic pain history and potential pelvic floor involvement, as part of multidisciplinary pain management**  
2. **Investigations:**  
   - **Repeat TV USS if pain persists** (assess for **adenomyosis, deep infiltrating endometriosis**)  
   - **Offer diagnostic laparoscopy with excision of visible lesions if pain persists after 3 months of medical therapy, as this patient has documented Stage II endometriosis with recurrent symptoms**  
   - **MRI pelvis if deep endometriosis suspected**  
3. **Follow-Up:**  
   - **Gynae clinic in 4/52** for reassessment  
   - **If HVS positive for infection: treat with abx per sensitivities**  
   - **If persistent pain: MDT discussion (pain team, gynae, physio)**  
   - **If laparoscopy is performed, discuss long-term postoperative hormone suppression (e.g., LNG-IUS or POP) for secondary prevention of recurrence, unless pregnancy is desired**  
4. **Patient Counselling:**  
   - **Advise on pain diary (timing, triggers, severity)**  
   - **Discuss GnRH analogues with add-back therapy as second-line option if first-line hormonal treatments fail, explaining potential side effects and need for bone protection**  

**Plan documented by: Dr. [Name], FY2**  
**Time: 1530 hours**  
**For: Consultant Gynaecology Review**  

*(This is a fictional case for educational purposes only.)*

--- Token Usage Report ---
Prompt tokens: 2080
Completion tokens: 1259
Total tokens: 3339
Estimated cost: $0.001669